CHEST Physician
-
Exciting opportunities for tobacco treatment: Unpacking the CMS changes
Changes enacted by CMS are embedding the integration of tobacco and nicotine addiction treatment more deeply into our nation’s health care system.
-
Top reads from the CHEST journal portfolio – November 2024
Dive into the healthy adherer effect in OSA, ICU stays for asthma, and COPD exacerbations related to medication use frequency
-
Extending exercise testing using telehealth monitoring in patients with ILD
The COVID-19 pandemic revolutionized the use of monitoring equipment in general and oxygen saturation monitoring devices as pulse oximeters in specific. Home technology devices such as home spirometry, smart apps, and wearable sensors combined with patient-reported outcome measures are increasingly used to monitor disease progression and medication compliance in addition to routine physical activity. The increasing adoption…
-
Major takeaways from the seventh world symposium on PH
The core definition of pulmonary hypertension (PH) remains a mean pulmonary arterial pressure (mPAP) > 20 mm Hg, with precapillary PH defined by a pulmonary arterial wedge pressure (PCWP) ≤ 15 mm Hg and pulmonary vascular resistance (PVR) > 2 Wood units (WU), similar to the 2022 European guidelines.1 2 There was recognition of uncertainty…
-
Mechanical power: A missing piece in lung-protective ventilation?
The ARDSNet trial demonstrated the importance of low tidal volume ventilation in patients with ARDS, and we have learned to monitor parameters such as plateau pressure and driving pressure (DP) to ensure lung-protective ventilation. However, severe hypercapnia can occur with low tidal volume ventilation and respiratory rate would often need to be increased. What role does the…
-
AI applications in pediatric pulmonary, sleep, and critical care medicine
Artificial intelligence (AI) refers to the science and engineering of making intelligent machines that mimic human cognitive functions, such as learning and problem solving.1AI tools are being increasingly utilized in pediatric pulmonary disease management to analyze the tremendous amount of patient data on environmental and physiological variables and compliance with therapy. Asthma exacerbations in young children…
-
Revival of the aspiration vs chest tube debate for PSP
Considerable heterogeneity exists in the management of primary spontaneous pneumothorax (PSP). American and European guidelines have been grappling with this question for decades: What is the best way to manage PSP? A 2023 randomized, controlled trial (Marx et al. AJRCCM) sought to answer this. The study recruited 379 adults aged 18 to 55 years between…
-
Advocating for diversity in medical education
Earlier this year, Representative Greg Murphy, MD, along with several cosponsors, introduced H.R. 7725, the Embracing Anti-Discrimination, Unbiased Curricula, and Advancing Truth in Education (EDUCATE) Act. If enacted, the EDUCATE Act would cut off federal funding to medical schools that force students or faculty to adopt specific beliefs; discriminate based on race or ethnicity; or…
-
Top reads from the CHEST journal portfolio – October 2024
Explore articles on PAP adherence, plasma biomarkers in ARDS, and airways disorders hospitalizations during wildfire season
-
Pseudomonas infection in patients with noncystic fibrosis bronchiectasis
Pseudomonas aeruginosa is a clinically important organism that infects patients with noncystic fibrosis bronchiectasis (NCFB). In the United States, the estimated prevalence of NCFB is 213 per 100,000 across all age groups and 813 per 100,000 in the over 65 age group.1 A retrospective cohort study suggests the incidence of NCFB as ascertained from International…
